Literature DB >> 7752840

A one year bioavailability study of coenzyme Q10 with 3 months withdrawal period.

K Folkers1, S Moesgaard, M Morita.   

Abstract

Twenty-one healthy subjects received oral Coenzyme Q10 supplementation in soft capsules of 30 mg t.i.d. for 9 months, followed by a withdrawal period of 3 months. Blood samples were taken before start of supplementation, after 3 and 9 months of supplementation, and finally 3 months after withdrawal. Average blood coenzyme Q10 concentration increased from about 1 mg/l before supplementation to about 2 mg/l after 3 and 9 months of supplementation, and returned to the pretreatment level after withdrawal. The rise of coenzyme Q10 concentration was statistically significant (P < 0.001, t-test).

Mesh:

Substances:

Year:  1994        PMID: 7752840     DOI: 10.1016/0098-2997(94)90039-6

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


  4 in total

1.  The Single-dose Absorption and Steady-state Bioavailability of Different Coenzyme Q10 Formulations.

Authors:  William V Judy
Journal:  Integr Med (Encinitas)       Date:  2022-02

2.  Significant Changes in Metabolic Profiles after Intervention with Selenium and Coenzyme Q10 in an Elderly Population.

Authors:  Urban Alehagen; Peter Johansson; Jan Aaseth; Jan Alexander; Izabella Surowiec; Katrin Lundstedt-Enkel; Torbjörn Lundstedt
Journal:  Biomolecules       Date:  2019-09-30

3.  Effects of coenzyme Q10 supplementation on glycemic control: A GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials.

Authors:  Ying Liang; Dan Zhao; Qiuhua Ji; Meitong Liu; Suming Dai; Shanshan Hou; Zhihao Liu; Yuheng Mao; Zezhong Tian; Yan Yang
Journal:  EClinicalMedicine       Date:  2022-08-03

4.  Supplementation with Selenium and Coenzyme Q10 Reduces Cardiovascular Mortality in Elderly with Low Selenium Status. A Secondary Analysis of a Randomised Clinical Trial.

Authors:  Urban Alehagen; Jan Alexander; Jan Aaseth
Journal:  PLoS One       Date:  2016-07-01       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.